Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota

2Section of Nephrology, The University of Chicago School of Medicine, Chicago, Illinois

3Institute of Physiology, University of Zurich, Zurich, Switzerland

4Division of Nephrology, Université Catholique de Louvain Medical School, Brussels, Belgium

5Division of Nephrology, University Medical Center Groningen, Groningen, The Netherlands

6Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts

7Biostatistics, Otsuka Pharmaceutical Development & Commercialization, Rockville, Maryland

8Global Medical Affairs, Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey

9Clinical Safety and Pharmacovigilance, Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey

10Global Clinical Development, Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey